Janssen Search
Search results
About Our Immunology Innovations
Redefining Treatment by Pioneering Pathway Science Retrovirus At Janssen Immunology, our vision is to restore health for the millions of people living with immune disease. Our approach to achieving this aspirational vision is systematic and evidence ...
Oncology Overview Page 2
Driving Toward the Elimination of Cancer At Janssen Oncology, we have a singular focus – the elimination of cancer. We are inspired by today’s tremendous progress and emerging new ideas, and we are driven by the enormous global unmet medical need in ...
Hepatitis B and the Burden it Inflicts
Hepatitis B and the Burden it Inflicts Article Type: Infectious Diseases & Vaccines At Janssen, we have an ambitious goal. We strive to bring forth medical innovations that improve the lives of people affected by hepatitis to ensure future ...
Final Analysis of Phase 2 GRIFFIN Study Presented for DARZALEX® (daratumumab)-based Investigational Quadruplet Regimen in Patients with Newly Diagnosed, Transplant-Eligible Multiple Myeloma
Aug 27, 2022 United States Data featured in plenary session at the 19th International Myeloma Society Annual Meeting LOS ANGELES, August 27, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the final results from the ...
Cancer Interception and the Tumor Microenvironment
Cancer Interception and the Tumor Microenvironment “We are intent on understanding what turns healthy cells into cancerous cells and continue to make progress in this area. These critical insights will help us advance medicines to interrupt the process ...
Janssen Stands United with Patients on World IBD Day 2018
Janssen Stands United with Patients on World IBD Day 2018 On May 19, we recognize World Inflammatory Bowel Disease (IBD) Day at Janssen by shedding light on the more than five million people around the world affected by Crohn’s disease and ulcerative ...
Committed to Advancing Prostate Cancer Innovation for Patients
Committed to Advancing Prostate Cancer Innovation for Patients As this year’s American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) is upon us, I’ve been reflecting on the tremendous progress that has been made in the ...
Connecting Clinical Research to Communities for Better Health Outcomes
Connecting Clinical Research to Communities for Better Health Outcomes In this article, senior Janssen leaders discuss strategies for shaping more diverse, inclusive, and equitable clinical trials. How many ways might Janssen—and the industry at large ...
Paul Duncan
PAUL DUNCAN SENIOR DIRECTOR EXTERNAL INNOVATION IMMUNOLOGY Paul Duncan is Senior Director, External Innovation for the Immunology Global Commercial Strategy Organization of Janssen Global Services. In this role, Paul is responsible for leading the overall ...
Working Together Toward Patient-Inspired Innovation
Working Together Toward Patient-Inspired Innovation We have redefined our existing relationship with patients by creating a Patient Engagement model where we engage with patients early, systematically, and directly on the most important aspects of drug ...